Continued focus on innovation to be presented by SGD Pharma at Pharmapack Europe 2023
Paris La Défense, FRANCE – 24 January 2022: Global market leader in glass primary packaging solutions, SGD Pharma, will present its new products and services on booths B68 and B70 at Pharmapack Europe held 1-2nd February 2023 in Paris, France.
The company will present IDENCY, the next generation of Type I glass vials that combines “easy to implement ” features on existing filling lines on top of superior strength, mechanical resistance and chemical durability. Developed as the solution for pharmaceutical companies facing increased supply chain pressures from the growing demand for parenteral drugs, the IDENCY technological innovation has been purposefully designed by SGD Pharma to complement existing portfolios and is uniquely suitable for parenteral drugs, especially the most sensitive ones. IDENCY is the solution of choice in cases of delamination issues, drug or buffer compatibility challenges, breakage or any supply chain shortage in converting vials.
Further innovations are accessible through its new Global Services Center, SGD Pharma Plus, which will allow customers to discover the wide array of options offered by SGD Pharma for additional features and finishes that enhance its pharma-grade vials. These include;
- Sterinity Ready-to-Use molded glass vials: which speed up time to market and reduce total cost of ownership as a result of increased quality and flexibility.
- Pre-treated glass for thermosealing applications: a ready-to-seal bottle treatment for an optimal hermetic seal, ideally suited for solid and powdered drugs that are sensitive to moisture such as antibiotics and VMS.
- Type I training tool: an educational platform that allows customers to benefit from SGD Pharma’s world-class expertise.
- Siliconization internal treatment: which maximizes product restitution while providing additional protection.
- Plastic coating and printing: helping to make your product stand out on shelves with unique customization options.
SGD Pharma will also display the extension of its unique Clareo range of high-quality Type II premium glass vials for injectable drugs, now also available in 10ml vials. As part of continuous improvement efforts to enhance glass performance and ensure patient safety, SGD Pharma developed Clareo premium glass vials to have a higher cosmetic quality and an increased uniform wall thickness.
SGD Pharma’s EasyLyo, vials more suited to extreme conditions encountered during the lyophilization process available in sizes 5,20,25,30,50 and 100ml, to be displayed.
Ensiemo, a child-resistant packaging solution ideally suited for cannabinoils and essential oils using pharmaceutical grade glass and accurate dropper dosage.
Sterinity Type I molded glass Ready-to-Use vials, mechanically resistant with high-quality sterilization and product validation processes that meet the rigorous requirements of the pharmaceutical industry and are suitable for multi-dose and intravenous drugs. Sterinity vials will be shown at Pharmapack in a range of sizes and glass colorways: including 20ml, 25ml, 50ml and 100ml, in both clear and amber glass. This range is the ideal solution for small batches of specialty drugs – and for companies requiring assurance that their packaging is truly compliant with current regulatory standards.
Olivier Rousseau, CEO, SGD Pharma, explains “We look forward to sharing our high-quality, innovative packaging solutions with the pharma community at Pharmapack. Since the industry has faced significant challenges of the past few years, with the ongoing impact of war, energy prices and supply chain pressures to name a few. This means that it is more important than ever to develop solutions to key industry challenges with new products that meet our customers’ needs and enable them to bring their drugs to market quickly and safely.”
Join us at our booths B68 and B70 to meet the team and find out more about our latest innovations.
